Matches in Wikidata for { <http://www.wikidata.org/entity/Q66403545> ?p ?o ?g. }
Showing items 1 to 44 of
44
with 100 items per page.
- Q66403545 description "assaig clínic" @default.
- Q66403545 description "clinical trial" @default.
- Q66403545 description "clinical trial" @default.
- Q66403545 description "clinical trial" @default.
- Q66403545 description "clinical trial" @default.
- Q66403545 description "ensaio clínico" @default.
- Q66403545 description "ensayo clínico" @default.
- Q66403545 description "ensayu clínicu" @default.
- Q66403545 description "essai clinique" @default.
- Q66403545 description "klinisch onderzoek" @default.
- Q66403545 description "клінічне випробування" @default.
- Q66403545 name "Efficacy and Safety of Eltrombopag + CSA in Patients With Moderate Aplastic Anemia (EMAA)" @default.
- Q66403545 name "Efficacy and Safety of Eltrombopag + CSA in Patients With Moderate Aplastic Anemia" @default.
- Q66403545 type Item @default.
- Q66403545 label "Efficacy and Safety of Eltrombopag + CSA in Patients With Moderate Aplastic Anemia (EMAA)" @default.
- Q66403545 label "Efficacy and Safety of Eltrombopag + CSA in Patients With Moderate Aplastic Anemia" @default.
- Q66403545 prefLabel "Efficacy and Safety of Eltrombopag + CSA in Patients With Moderate Aplastic Anemia (EMAA)" @default.
- Q66403545 prefLabel "Efficacy and Safety of Eltrombopag + CSA in Patients With Moderate Aplastic Anemia" @default.
- Q66403545 P1050 Q66403545-7D3B41ED-218F-4FBE-B6E9-3AC86BD2B197 @default.
- Q66403545 P1132 Q66403545-9B90263D-091C-48B3-A35C-505AC8D4F922 @default.
- Q66403545 P1476 Q66403545-1E9C15B8-A783-46B9-A56F-16620F5746EA @default.
- Q66403545 P17 Q66403545-D8DD3293-B6E0-434E-A3F6-25E1B84D18DA @default.
- Q66403545 P1813 Q66403545-F20B6B4C-6338-4460-B119-A2427C857341 @default.
- Q66403545 P2899 Q66403545-8AEFCC33-C6F4-4655-BFB8-D1428746772E @default.
- Q66403545 P3098 Q66403545-BCC9D5BA-0FA8-4C3A-A384-43BB5BDF8512 @default.
- Q66403545 P31 Q66403545-0CD25EB8-7E10-4778-A348-B88FE24A0789 @default.
- Q66403545 P580 Q66403545-7026CD80-EA71-44FD-892E-A347068988EC @default.
- Q66403545 P582 Q66403545-9CCE58E8-08C8-42EB-B387-CEC9B2918A6E @default.
- Q66403545 P6099 Q66403545-396FFDF6-55E8-4AEA-B9F5-F6E009EBCDE9 @default.
- Q66403545 P6099 Q66403545-633F4475-56D1-411A-9C7F-F5F51571F662 @default.
- Q66403545 P8363 Q66403545-049B2DEE-E77F-45B8-86C0-6847904B4E9E @default.
- Q66403545 P1050 Q5445 @default.
- Q66403545 P1132 "+116" @default.
- Q66403545 P1476 "Efficacy and Safety of Thrombopoetin-Receptor Agonist Eltrombopag in in Combination With Ciclosporin A in Moderate Aplastic Anemia (EMAA): Prospective Randomized Multicenter Study" @default.
- Q66403545 P17 Q183 @default.
- Q66403545 P1813 "EMAA" @default.
- Q66403545 P2899 "+18" @default.
- Q66403545 P3098 "NCT02773225" @default.
- Q66403545 P31 Q30612 @default.
- Q66403545 P580 "2015-01-27T00:00:00Z" @default.
- Q66403545 P582 "2022-09-30T00:00:00Z" @default.
- Q66403545 P6099 Q42824440 @default.
- Q66403545 P6099 Q42824827 @default.
- Q66403545 P8363 Q78089383 @default.